CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr | ₹1,313 Cr | ₹1,049 Cr |
What is the latest Total Liabilities ratio of CONCORD BIOTECH ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,701 Cr |
Mar2023 | ₹1,514 Cr |
Mar2022 | ₹1,502 Cr |
Mar2021 | ₹1,313 Cr |
Mar2020 | ₹1,049 Cr |
How is Total Liabilities of CONCORD BIOTECH Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,701 Cr | 12.33 | |
Mar2023 | ₹1,514 Cr | 0.81 | |
Mar2022 | ₹1,502 Cr | 14.41 | |
Mar2021 | ₹1,313 Cr | 25.18 | |
Mar2020 | ₹1,049 Cr | - |
Compare Total Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹16,741.8 Cr | -5.9% | -11.5% | 3.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -5.9% |
-11.5% |
3.6% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses